There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To explore various methods for assessing the early response to vascular endothelial
growth factor (VEGF) inhibitors for neovascular age-related macular degeneration and
investigate their association with 3-year visual acuity (VA) outcomes.